A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy

• Published in: PloS one Vol. 11; no. 9; p. e0160437
• Main Authors: Yang, Yue, Ma, Ye-ping, Chen, Da-peng, Zhuo, Li, Li, Wen-ge
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 06.09.2016; Public Library of Science (PLoS)
• Subjects: Analogs; Antigens; Antiretroviral agents; Antiviral agents; Antiviral Agents - therapeutic use; Antiviral drugs; Bias; Biology and Life Sciences; Care and treatment; Chronic infection; Drugs; Gastroenterology; Glomerulonephritis, Membranous - drug therapy; Glomerulonephritis, Membranous - etiology; Glomerulonephritis, Membranous - virology; Hepatitis; Hepatitis B; Hepatitis B - complications; Hepatitis B - drug therapy; Hepatitis B - virology; Hepatitis B e antigen; Hepatitis B e Antigens - drug effects; Hepatitis B virus; Hepatitis B virus - drug effects; Hepatitis B virus - pathogenicity; Humans; Infections; Interferon; Interferons - therapeutic use; Kidneys; Liver; Medicine and Health Sciences; Membranous nephropathy; Meta-analysis; Nephrology; Nephropathy; Nucleoside analogs; Nucleosides; Nucleosides - therapeutic use; Patients; Physical Sciences; Proteinuria; Remission; Research and Analysis Methods; Risk assessment; Studies; Systematic review; Therapy; Viruses

Hepatitis B virus-associated membranous nephropathy (HBV-MN) is the most common renal extra-hepatic manifestation in patients with chronic HBV infection. In September 2015, we searched the MEDLINE, EMBASE, and CENTRAL databases, and the reference lists of retrieved articles, to identify relevant stu...